Welcome to the e-CCO Library!

P372: Accelerated dosing schedule with ustekinumab in anti-TNF refractory Crohn`s disease
Year: 2022
Source: ECCO'22
Authors: Aleman Gonzalez, H.(1);Stamp, K.(1);Whitehead, E.(1);Pattinson, A.(1);Turnbull, J.(1);Myers, S.(1);Talbot, A.(1);Sebastian, S.(1);
Created: Friday, 11 February 2022, 3:52 PM
P372: Effectiveness and safety of immunosuppressants for pouch disorders: results from the RESERVO Study of GETECCU
Year: 2021
Source: ECCO'21 Virtual
Authors: Mesonero Gismero, F.(1);Zabana, Y.(2);Fernández-Clotet, A.(3);Leo, E.(4);Caballol, B.(3);Núñez, A.(4);García, M.J.(5);Bertoletti, F.(6);Mínguez, A.(7);Suris, G.(8);Casis, B.(9);Ferreiro-Iglesias, R.(10);Calafat, M.(11);Jiménez, I.(12);Miranda-Bautista, J.(13);Lamuela, L.J.(14);Fajardo, I.(15);Torrealba, L.(16);Nájera, R.(17);Sáiz, R.M.(18);González, I.(19);Vicuña, M.(20);García-Morales, N.(21);Gutiérrez, A.(22);López-García, A.(23);Benítez, J.M.(24);Rubín de Célix, C.(25);Tejido, C.(26);Brunet, E.(27);Hernández, A.(28);Suárez, C.(29);Piqueras, M.(30);Castaño, A.(31);Ramos, L.(32);Sobrino, A.(33);Rodríguez-Grau, M.C.(34);Elosua, A.(35);Montoro, M.(36);López-Sanromán, A.(1);Barreiro-de Acosta, M.(10);
Created: Wednesday, 2 June 2021, 4:12 PM
P372: Endoscopic ultrasonography in the differential diagnosis of Ulcerative colitis and Crohn's disease.
Year: 2023
Source: ECCO’23 Copenhagen
Authors: BelousovaHead of Gastroenterology Clinic and IBD, E.(1)*;
Created: Friday, 14 July 2023, 11:05 AM
P372: Neurological symptoms and imaging abnormalities in brain MRI in patients with Crohn’s disease receiving anti-TNFa therapy
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

M. Papatheodoridi*1, A. Euthumiou2, N. Perlepe3, F. Gagas3, M. Gizis3, S. Lagou3, G. Kounadis3, J. Koutsounas3, G. Bamias3

Created: Friday, 22 February 2019, 9:41 AM
P372: The long term course of patients undergoing ileal pouch-anal anastomosis for ulcerative colitis
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Macaluso F.S.*1, Rossi F.2, Orlando A.1, Sapienza C.1, Sinagra E.2, Maisano S.1, Angelo C.1, Renna S.1, Linea C.3, Montalbano L.M.3, Giunta M.3, Solina G.4, Marchesa P.5, Ventimiglia M.1, Cottone M.1

Created: Wednesday, 20 February 2019, 10:36 AM
P373 Telemedicine and inflammatory bowel disease: Results of the IBD assistant pilot project
Year: 2020
Source:

ECCO'20 Vienna

Authors:

K. Malickova1,2, V. Pesinova1, M. Bortlik1,3,4, D. Duricova1,3, N. Machkova1, V. Hruba1, M. Lukas1,5, K. Mitrova1,6, M. Vasatko1, M. Kostrejova1,7, M. Kolar1,5, M. Lukas1,2

Created: Thursday, 30 January 2020, 10:12 AM
P373: Adjunctive hyperbaric oxygen therapy promotes successful healing in patients with refractory Crohn’s disease
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

M. Ribeiro Feitosa1, R. S. Parra*1, O. Feres Filho2, J. J. Ribeiro da Rocha1, O. Féres1

Created: Friday, 22 February 2019, 9:49 AM
P373: An Unusual Occurrence of Right-sided Colonic Neuroendocrine Carcinoma in Ulcerative Colitis – A case report
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Alessa, S.(1)*;Aldraiweesh, S.(2);Albogami, F.(2);
Created: Friday, 14 July 2023, 11:05 AM
P373: Daily aspirin use does not impact clinical outcomes in patients with inflammatory bowel disease
Year: 2018
Source: ECCO '18 Vienna
Authors:

P. Patel*, G. Gao, G. Gulotta, D.T. Rubin, S. Dalal, R.D. Cohen, A. Sakuraba, J. Pekow

Created: Thursday, 21 February 2019, 9:14 AM
P373: Effect of risankizumab on improved and sustained quality of life in patients with moderate to severe Crohn’s disease: Phase 2 trial results
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

E. Louis*1, W. J. Sandborn2, G. D’Haens3, F. Baert4, J. Kalabic5, K. Wallace6, W-J. Lee6, B. G. Feagan7

Created: Friday, 22 February 2019, 9:41 AM
P373: Psoriasis and psoriasiform skin lesions in patients with Inflammatory Bowel Disease treated with infliximab: a pharmacokinetic analysis
Year: 2021
Source: ECCO'21 Virtual
Authors: Rodrigues, I.(1);Damião, F.(1);Serrazina, J.(1);Fernandes, S.(1);Bernardo, S.(1);Gonçalves, A.R.(1);Moura Santos, P.(1);Baldaia, C.(1);Valente, A.(1);Correia, L.(1);Tato Marinho, R.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P373: Real world evidence of tofacinitib in ulcerative colitis: short and long-term effectiveness, impact of extraintestinal manifestations and immunomediated diseases and safety
Year: 2022
Source: ECCO'22
Authors: Chaparro, M.(1);Acosta, D.(1);Rodríguez, C.(2);Vicuña, M.(2);Mesonero, F.(3);Barreiro-de Acosta, M.(4);Fernández-Clotet, A.(5);Hernández Martínez, Á.(6); Arroyo, M.T.(7);Vera Mendoza, I.(8);Sicilia, B.(9);Muñoz Villafranca, C.(10);Castro-Poceiro, J.(11);Martínez Cadilla, J.(12);Vázquez Morón, J.M.(13);Montil, E.(14);Sierra-Ausín , M.(15);Calafat, M.(16); Leo Carnerero, E.(17);Manceñido Marcos, N.(18);Torrealba M, L.(19); Alonso-Galán, H.(20); Benítez, J.M.(21);Ber Nieto, Y.(22);Cabello Tapia, M.J.(23);Diz-Lois Palomares, M.T.(24);García, M.J.(25);Armesto González, E.M.(26);Calvet Calvo, X.(27);Piqueras, M.(28);Dueñas Sadornil, C.(29); Pérez Calle, J.L.(30);Botella, B.(31); Martínez-Pérez, T.D.J.(32);Ramos, L.(33);Rodríguez-Grau, M.C.(34);Fernández Forcelledo, J.L.(35); Gutiérrez, A.(36);Sesé Abizanda, E.(37);Gisbert, J.P.(1);
Created: Friday, 11 February 2022, 3:52 PM
P373: Real-file prospective experience with adalimumab in inducing remission in ulcerative colitis in Italian primary inflammatory bowel diseases centres
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Tursi A.*1, Allegretta L.2, Della Valle N.3, Elisei W.4, Forti G.5, Faggiani R.6, Lorenzetti R.7, Mocci G.8, Penna A.9, Pranzo G.10, Paiano P.11, Ricciardelli C.11, Gallina S.6, Picchio M.12

Created: Wednesday, 20 February 2019, 10:36 AM
P374 Disease course and fate of Crohn’s perianal fistula patients following failure of initial biologic therapy: real-world lessons on the impact of refractory disease from a tertiary centre cohort
Year: 2020
Source:

ECCO'20 Vienna

Authors:

S. Adegbola, W.Y. Mak, K. Sahnan, S. Hiles, P. Bassett, P. Lung, J. Warusavitarne, O. Faiz, R. Phillips, P. Tozer, A. Hart

Created: Thursday, 30 January 2020, 10:12 AM
P374: Effects of subcutaneous vedolizumab on health-related quality of life and work productivity in patients with ulcerative colitis: results from the Phase 3 VISIBLE 1 trial
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

S. Vermeire1, Ž. Krznarić2, T. Kobayashi3, J. Chen4, C. Agboton5, K. Kisfalvi4, H. Patel*6, W. Sandborn7

Created: Friday, 22 February 2019, 9:41 AM
P374: Efficacy of a micronised, dispersible ferric pyrophosphate in children with anaemia associated with inflammatory bowel disease.
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

A. Wegner*1, G. Mierzwa2, S. Wiecek3, A. Korlatowicz- Bilar4, M. Dadalski5, B. Korczowski6, J. Kierkus7

Created: Friday, 22 February 2019, 9:49 AM
P374: Front loading infliximab dosing regimen improves outcomes in Crohn’s Disease perianal fistulas
Year: 2022
Source: ECCO'22
Authors: Lloyd, A.(1);Wilkinson, A.(2);Aleman Gonzalez, H.(2);Ramachandran, S.(2);Whitehead, E.(2);Pattinson, A.(2);Stamp, K.(2);Turnbull, J.(2);Talbot, A.(2);Sebastian, S.(2);
Created: Friday, 11 February 2022, 3:52 PM
P374: Home or hospital-based analysis of stool calprotectin: assessing two methods for monitoring inflammatory bowel disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Heida A.*1, Knol M.1, Muller Kobold A.2, Dijkstra G.3, van Rheenen P.1

Created: Wednesday, 20 February 2019, 10:36 AM
P374: Non-alcoholic fatty liver disease in inflammatory bowel disease: Prevalence and risk factors
Year: 2018
Source: ECCO '18 Vienna
Authors:

G. Losurdo1*, A. Iannone2, M. Mangia3, E. Shahini2, F. Albano2, S.F. Rizzi2, R.F. La Fortezza2, R. Lovero2, A. Contaldo2, M. Barone2, G. Leandro4, E. Ierardi2, A. Di Leo2, M. Principi2

Created: Thursday, 21 February 2019, 9:14 AM
P374: Safety and drug survival of methotrexate versus tioguanine after failure of conventional thiopurines in patients with Crohn’s disease.
Year: 2021
Source: ECCO'21 Virtual
Authors: Savelkoul, E.(1);Maas, M.(1);Bourgonje, A.(2);Crouwel, F.(3);Russel, M.(4);Römkens, T.(5);De Boer, N.(3);Dijkstra, G.(2);Hoentjen, F.(1);
Created: Wednesday, 2 June 2021, 4:12 PM